Persistence of Zika virus in body fluids of patients with Zika virus infection (360G-Wellcome-206522_Z_17_Z)
The purpose of this study is to assess the presence and duration of infectious Zika virus (ZIKV) and related markers (ZIKV-specific RNA, antigen, antibodies, T-cell response, and innate immunity) in blood, semen, saliva, oral fluid (saliva and crevicular fluid), urine, vaginal secretions, menstrual blood, rectal swab, tears, sweat and breast milk of infected individuals who present to clinics during acute illness and convalescence, and in comparison to their symptomatic or asymptomatic household contacts. To also relate these parameters to host immunity over time and across different body fluids, to socio-demography as well as other host and environmental factors.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 126798 |
| Applicant Surname | de Filippis |
| Approval Committee | Internal Decision Panel |
| Award Date | 2017-05-15T00:00:00+00:00 |
| Financial Year | 2016/17 |
| Grant Programme: Title | Zika Initiative Award |
| Internal ID | 206522/Z/17/Z |
| Lead Applicant | Dr Ana de Filippis |
| Partnership Name | Zika Research Support Initiative |
| Partnership Value | 253597 |
| Planned Dates: End Date | 2018-07-03T00:00:00+00:00 |
| Planned Dates: Start Date | 2017-04-03T00:00:00+00:00 |
| Recipient Org: Country | Brazil |
| Region | International |